Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. comply with Leber hereditary optic neuropathy diagnostic criteria.~2. in patients with informed consent, voluntary participation.~3. signed informed consent.~4. 8 ≤ Age ≤ 60 years old, good health, the patient can tolerate local anesthesia surgery.~5. to comply with doctor's instructions, can in the time of referral.~Exclusion Criteria:~1. Cardiopulmonary and renal function in severe weakness, cancer, a variety of bleeding disorders, acute sensing disease, high fever, high fever disease, women during pregnancy, heart disease, such as post-operative recovery period.~2. Are participating in other clinical studies of patients.~3. Patients with mental disorders.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- rAAV2-ND4 (Type: EXPERIMENTAL): injection

Based on this trial design, predict the completion outcome and termination type (if applicable).